Literature DB >> 19682010

Review article: management of acute severe and near-fatal asthma.

Anthony D Holley1, Robert J Boots.   

Abstract

Despite a decline in the Australian overall asthma mortality, near-fatal/critical asthma continues to be a significant management issue for emergency physicians and intensivists. Near-fatal asthma is a unique subtype of asthma, with a variety of clinical presentations, requiring rapid and aggressive intervention. The pharmacological and non-pharmacological management of near-fatal asthma remains very complex. The present review discusses recent advances and evidence for current available strategies targeting this time critical emergency.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682010     DOI: 10.1111/j.1742-6723.2009.01195.x

Source DB:  PubMed          Journal:  Emerg Med Australas        ISSN: 1742-6723            Impact factor:   2.151


  4 in total

Review 1.  Acute lung failure.

Authors:  Rob Mac Sweeney; Daniel F McAuley; Michael A Matthay
Journal:  Semin Respir Crit Care Med       Date:  2011-10-11       Impact factor: 3.119

2.  Risk factors, management and outcomes of patients admitted with near fatal asthma to a tertiary care hospital in Riyadh.

Authors:  Hasan M Al-Dorzi; Haifa A Al-Shammary; Salha Y Al-Shareef; Hani M Tamim; Khaled Shammout; Abdulaziz Al Dawood; Yaseen M Arabi
Journal:  Ann Thorac Med       Date:  2014-01       Impact factor: 2.219

Review 3.  Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment.

Authors:  Ondrej Soukup; Michael Winder; Uday Kumar Killi; Vladimir Wsol; Daniel Jun; Kamil Kuca; Gunnar Tobin
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

4.  Extracorporeal membrane oxygenation for life-threatening asthma refractory to mechanical ventilation: analysis of the Extracorporeal Life Support Organization registry.

Authors:  Hye Ju Yeo; Dohyung Kim; Doosoo Jeon; Yun Seong Kim; Peter Rycus; Woo Hyun Cho
Journal:  Crit Care       Date:  2017-12-06       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.